Assessing the Efficacy of Romosozumab in Postmenopausal Osteoporosis
This comprehensive meta-analysis provides robust evidence that romosozumab is an effective and safe treatment option for postmenopausal osteoporosis, with superior effects on BMD and bone formation biomarkers compared with other interventions. These findings support the use of romosozumab to improve clinical outcomes in this patient population.
Authors
- Gonzalo Mariscal (ORCID: https://orcid.org/0000-0002-5166-198X)
- Bartolomé Lladó Ferrer
- Jaume Mateu (ORCID: https://orcid.org/0000-0003-4469-9944)
- Sabina Herrera (ORCID: https://orcid.org/0000-0002-5057-354X)
- César Antonio Egües Dubuc (ORCID: https://orcid.org/0000-0002-3637-1239)
- Marina Soledad Moreno García
Institutions
- Valencia Catholic University Saint Vincent Martyr (ES)
- Hospital Son Llatzer (ES)
- Hospital Universitario Miguel Servet (ES)
Publication Details
- Journal
- JCR Journal of Clinical Rheumatology
- Published
- 2025-05-05
- DOI
- https://doi.org/10.1097/rhu.0000000000002241
- Citations
- 1
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 1.72